(ESLT) Elbit Systems - Overview
Sector: Industrials | Industry: Aerospace & Defense | Exchange: NASDAQ (USA) | Market Cap: 36.070m USD | Total Return: 100.3% in 12m
Avg Turnover: 87.4M
EPS Trend: 95.5%
Qual. Beats: 8
Rev. Trend: 99.6%
Qual. Beats: 1
Warnings
Below Avwap Earnings
Tailwinds
Rs Leader, Idiosyncratic Leader, Confidence
Elbit Systems Ltd. (ESLT) is an Israel-based international defense contractor that develops and supplies systems for the aerospace, land, and naval sectors. The company operates through five specialized segments focusing on C4I and Cyber, electronic warfare, intelligence surveillance, and unmanned aerial solutions. Its portfolio includes precision-guided munitions, flight simulators, and autonomous systems for government and commercial clients worldwide.
The defense industry is characterized by high barriers to entry due to stringent regulatory frameworks and long-term government procurement cycles. Elbit Systems utilizes a diversified business model that integrates hardware manufacturing with high-margin software and support services, providing recurring revenue through maintenance and system upgrades. For a deeper analysis of the companys valuation metrics, visit ValueRay.
Headquartered in Haifa and incorporated in 1966, the company maintains a significant global footprint with major operations in North America and Europe. Its technological focus extends beyond traditional defense into homeland security and medical instrumentation, leveraging dual-use technologies to address multi-domain security challenges.
- Rising global defense budgets drive record order backlog and revenue growth
- Israel-Hamas conflict increases domestic procurement and operational supply chain pressure
- Expansion of European defense spending accelerates land and aerospace segment sales
- High interest rates and labor costs compress operating margins despite volume
- Geopolitical instability in the Middle East impacts regional risk premium and valuation
| Net Income: 543.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.54 > 1.0 |
| NWC/Revenue: 21.80% < 20% (prev 15.32%; Δ 6.48% < -1%) |
| CFO/TA 0.06 > 3% & CFO 794.9m > Net Income 543.8m |
| Net Debt (724.3m) to EBITDA (861.4m): 0.84 < 3 |
| Current Ratio: 1.29 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.8m) vs 12m ago 6.28% < -2% |
| Gross Margin: 24.38% > 18% (prev 0.24%; Δ 2.41k% > 0.5%) |
| Asset Turnover: 68.27% > 50% (prev 62.10%; Δ 6.16% > 0%) |
| Interest Coverage Ratio: 4.92 > 6 (EBITDA TTM 861.4m / Interest Expense TTM 139.8m) |
| A: 0.14 (Total Current Assets 7.74b - Total Current Liabilities 5.98b) / Total Assets 12.7b |
| B: 0.25 (Retained Earnings 3.15b / Total Assets 12.7b) |
| C: 0.06 (EBIT TTM 687.2m / Avg Total Assets 11.8b) |
| D: 0.36 (Book Value of Equity 3.07b / Total Liabilities 8.53b) |
| Altman-Z'' = 2.49 = A |
| DSRI: 0.95 (Receivables 3.57b/3.18b, Revenue 8.07b/6.81b) |
| GMI: 0.99 (GM 24.38% / 24.05%) |
| AQI: 0.93 (AQ_t 0.24 / AQ_t-1 0.26) |
| SGI: 1.18 (Revenue 8.07b / 6.81b) |
| TATA: -0.02 (NI 543.8m - CFO 794.9m) / TA 12.7b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of May 26, 2026, the stock is trading at USD 767.82 with a total of 134,700 shares traded.
Over the past week, the price has changed by +2.37%,
over one month by -6.32%,
over three months by +1.74% and
over the past year by +100.28%.
Elbit Systems has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold ESLT.
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 900.5 | 17.3% |
P/E Trailing = 67.6316
P/E Forward = 9.6618
P/S = 4.5436
P/B = 8.8531
P/EG = 8.7866
Revenue TTM = 8.07b USD
EBIT TTM = 687.2m USD
EBITDA TTM = 861.4m USD
Long Term Debt = 255.6m USD (from longTermDebt, last quarter)
Short Term Debt = 232.5m USD (from shortTermDebt, last quarter)
Debt = 1.54b USD (from shortLongTermDebtTotal, last quarter) + Leases 575.2m
Net Debt = 724.3m USD (calculated: Debt 1.54b - CCE 815.9m)
Enterprise Value = 36.8b USD (36.1b + Debt 1.54b - CCE 815.9m)
Interest Coverage Ratio = 4.92 (Ebit TTM 687.2m / Interest Expense TTM 139.8m)
EV/FCF = 65.23x (Enterprise Value 36.8b / FCF TTM 564.0m)
FCF Yield = 1.53% (FCF TTM 564.0m / Enterprise Value 36.8b)
FCF Margin = 6.99% (FCF TTM 564.0m / Revenue TTM 8.07b)
Net Margin = 6.74% (Net Income TTM 543.8m / Revenue TTM 8.07b)
Gross Margin = 24.38% ((Revenue TTM 8.07b - Cost of Revenue TTM 6.10b) / Revenue TTM)
Gross Margin QoQ = 24.66% (prev 24.89%)
Tobins Q-Ratio = 2.91 (Enterprise Value 36.8b / Total Assets 12.7b)
Interest Expense / Debt = 9.08% (Interest Expense 139.8m / Debt 1.54b)
Taxrate = 11.08% (21.4m / 193.5m)
NOPAT = 611.1m (EBIT 687.2m * (1 - 11.08%))
Current Ratio = 1.29 (Total Current Assets 7.74b / Total Current Liabilities 5.98b)
Debt / Equity = 0.37 (Debt 1.54b / totalStockholderEquity, last quarter 4.13b)
Debt / EBITDA = 0.84 (Net Debt 724.3m / EBITDA 861.4m)
Debt / FCF = 1.28 (Net Debt 724.3m / FCF TTM 564.0m)
Total Stockholder Equity = 3.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.60% (Net Income 543.8m / Total Assets 12.7b)
RoE = 14.14% (Net Income TTM 543.8m / Total Stockholder Equity 3.84b)
RoCE = 16.76% (EBIT 687.2m / Capital Employed (Equity 3.84b + L.T.Debt 255.6m))
RoIC = 8.83% (NOPAT 611.1m / Invested Capital 6.92b)
WACC = 5.47% (E(36.1b)/V(37.6b) * Re(5.36%) + D(1.54b)/V(37.6b) * Rd(9.08%) * (1-Tc(0.11)))
Discount Rate = 5.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 64.44 | Cagr: 3.05%
[DCF] Terminal Value 77.97% ; FCFF base≈466.2m ; Y1≈534.5m ; Y5≈786.6m
[DCF] Fair Price = 237.5 (EV 11.8b - Net Debt 724.3m = Equity 11.1b / Shares 46.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.49 | EPS CAGR: 26.73% | SUE: 4.0 | # QB: 8
Revenue Correlation: 99.57 | Revenue CAGR: 15.93% | SUE: 0.98 | # QB: 1
EPS current Quarter (2026-06-30): EPS=3.55 | Chg30d=+6.87% | Revisions=+0% | Analysts=4
EPS current Year (2026-12-31): EPS=15.07 | Chg30d=+8.75% | Revisions=+50% | GrowthEPS=+18.2% | GrowthRev=+13.1%
EPS next Year (2027-12-31): EPS=17.33 | Chg30d=+10.01% | Revisions=+43% | GrowthEPS=+14.9% | GrowthRev=+9.6%
[Analyst] Revisions Ratio: +50%